Lv1
90 积分 2025-09-16 加入
NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer
1个月前
已完结
Disrupting Paraspeckle Stability by Targeting WTX–NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer
1个月前
已完结
Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples
1个月前
已完结
Abstract A008: Intracranial metastases in patients with Claudin 18.2 positive metastatic gastroesophageal cancers
1个月前
已关闭
Spatial Profiling of Patient-Matched HER2 Positive Gastric Cancer Reveals Resistance Mechanisms to Trastuzumab and Trastuzumab Deruxtecan
1个月前
已完结
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia
2个月前
已关闭
Perspectives on the pharmacological management of esophageal cancer: where are we now and where do we need to go?
2个月前
已完结
[Esophageal cancer: new developments in prevention and therapy]
2个月前
已完结
Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type Endocervical Lesions and their Differential Diagnoses
2个月前
已完结
Zolbétuximab en association à la chimiothérapie dans les adénocarcinomes gastriques ou de la jonction œsogastrique localement avancés non résécables ou métastatiques, HER2 négatifs et CLDN 18.2 positifs
2个月前
已关闭
皖公网安备34019202002308
